vimarsana.com
  1. Home
  2. Live Updates
  3. Steve Scala Cowen - Breaking News

Page 6 - Steve Scala Cowen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer (PFE) Q2 2022 Earnings Call Transcript

PFE earnings call for the period ending June 30, 2022.

Andrew baumChris shibutaniWilliam paoLouise chen cantor fitzgeraldTerence flynnElliott boscoAndrew baum citiGeoff meachamSteve scala cowenCarter gould barclaysTerence flynn morgaAamir malikKathrin jansenLouise chenCharlotte allertonKaiser permanente

Bristol Myers Squibb (BMY) Q2 2022 Earnings Call Transcript

BMY earnings call for the period ending June 30, 2022.

United kingdomUnited statesAndrew baumRaymond jamesChris boernerChris shibutaniTerence flynn morgan stanleyTerence flynnGiovanni caforioAndrew baum citiGeoff meachamCarter gould barclaysSteve scala cowenSeamus fernandez guggenheimFucosylated probodyMatthew phipps william blair

Zoetis (ZTS) Q1 2022 Earnings Call Transcript

ZTS earnings call for the period ending March 31, 2022.

United statesFrance generalSteve frankRaymond jamesErin wrightGoldman sachsBalaji prasad barclaysElliott wilburBalaji prasadErin wright morgan stanleyLouise chen cantor fitzgeraldWetteny josephKristin peckSteve scala cowenSteve scalaMichael ryskin

Eli Lilly and Company (LLY) Q1 2022 Earnings Call Transcript

LLY earnings call for the period ending March 31, 2022.

United statesSaudi arabiaMike masonDave ricksAndrew baumIlya yuffaEli lillyChris shibutaniTerence flynn morgan stanleyLouise chen cantor fitzgeraldTerence flynnAndrew baum citiKerry holfordGeoff meachamSteve scala cowenSeamus fernandez guggenheim

Bristol Myers Squibb (BMY) Q1 2022 Earnings Call Transcript

BMY earnings call for the period ending March 31, 2022.

Luisa hectorAndrew baumRaymond jamesTim andersonChris boernerEvan seigermanChris shibutaniLuisa hector berenbergTerence flynn morgan stanleyTerence flynnSamit hirawatBristol myers squibbGiovanni caforioAndrew baum citiGeoff meachamSteve scala cowen

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.